Souhaitez-vous accéder aux communiqués récents ?

Microbot Medical®’s LIBERTY® Endovascular Robotic System Highlighted at a Leading Vascular Disease Management Conference

ST. LOUIS, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the launch...

Microbot Medical® to Leverage Current Users Experience of LIBERTY® at Key Oncology Conference to Support Commercial Adoption.

Dublin, Jan. 22, 2026 (GLOBE NEWSWIRE) -- The "Pharmaceutical Collaborative Robots Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031" has been added to ...

Microbot Medical Continues its 2025 Momentum; Announces Key 2026 Milestones

Dublin, Dec. 02, 2025 (GLOBE NEWSWIRE) -- The "Artificial Muscle Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ...

Dublin, Dec. 02, 2025 (GLOBE NEWSWIRE) -- The "Healthcare Robotics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ...

Boston, Nov. 26, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “Humanoid Robot: Applications Verticals and Global Markets” is expected to grow from $1.9 billion in 2025...

Microbot Medical® Announces Emory University Hospital as the First Hospital in the World to Adopt the New LIBERTY® Endovascular Robotic System

Microbot Medical® Commences the Limited Market Release of its LIBERTY® Endovascular Robotic System in the U.S.